Experiencing itchiness is not only bothersome but can lead to prolonged scratching, sleep disturbances, and general frustration.
The intriguing question of why we itch, even without an apparent cause, has been explored by scientists at Harvard Medical School, and they believe they’ve uncovered the answer. The culprit is a specific type of bacteria known as staphylococcus aureus, which directly affects nerve cells, inducing the sensation of itching.
Conducting experiments on mice, the researchers exposed their skin to this bacteria, observing the development of persistent itching and heightened sensitivity over time.
This heightened sensitivity, similar to conditions like eczema, extended reactions to stimuli that wouldn’t typically provoke itching. Through meticulous analysis, the scientists identified a key bacterial enzyme, V8, that activates the protein PAR1 on skin cells, responsible for signaling sensations like pain, heat, and itch to the brain.
Further experimentation involved altering versions of the bacteria to pinpoint the specific molecular component triggering the itch. The identified enzyme, V8, proved significant, and the researchers successfully alleviated itching and skin damage in mice by employing an already approved anti-clotting drug targeting the PAR1 protein.
Dr. Liwen Deng, one of the study’s authors, highlighted the potential for this drug to serve as an anti-itch medication for humans, possibly integrated into future creams. The groundbreaking research sheds light on the microbial origin of itching and opens avenues for novel therapeutic approaches.
#MaltaDaily
